m+Medelevator.RU
← Поиск публикаций
Nihon Sanka Fujinka Gakkai zasshi · 1992

[Characterization of two novel cell lines established from a single human uterine cervical adenocarcinoma, and their chemosensitivities and hormonal effects on their proliferation].

Аннотация на английскомСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Fushiki H

Аннотация

Two new cell lines were established from a single human uterine cervical adenocarcinoma which had been successfully transplanted into nude mice. They were subcultivated more than 70 times over a period of 46 months and designated as TCO-1 and TCO-2, respectively. Growth characteristics, modes of chromosomes and specific tumor makers were different in TCO-1 and TCO-2. The plating efficiency of TCO-1 was greater and its doubling time was shorter than those of TCO-2. Modes of chromosomes were 77 in TCO-1 and 94 in TCO-2. Their chemosensitivities to 13 anticancer drugs were studied by MTT assay. Only the mitomycin C (MMC) was an effective agent for both TCO-1 and TCO-2 cell lines which were characteristically different from each other. The results suggest that MMC would be a promising agent for chemotherapy of human uterine cervical adenocarcinoma. The influences of 6 hormones (estradiol, progesterone, dihydrotestosterone, medroxyprogesterone acetate, human menopausal gonadotropin, human chorionic gonadotropin) on their proliferation were studied by MTT assay and dye exclusion assay. TCO-1 and TCO-2 showed no significant changes in proliferation in any of them. It is suggested that hormone replacement therapy could be indicated even for postoperative patients with cervical adenocarcinoma.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты